DocumentsTable of Contents Back to Top
DATES: Back to Top
The proposed rule published July 2, 2014 (79 FR 37687) is corrected as of November 17, 2014.
FOR FURTHER INFORMATION CONTACT: Back to Top
Edisa Gozun, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Rm. 5199, Silver Spring, MD 20993-0002, 301-796-3110.
SUPPLEMENTARY INFORMATION: Back to Top
In FR Doc. 2014-15371, appearing on page 37687 in the Federal Register of July 2, 2014 (79 FR 37687), FDA is making the following correction:
1. On page 37687, in the first column, the RIN number heading is corrected to read “RIN 0910-AH08”.
2. On page 37687, in the second column, the RIN number under the ADDRESSES heading is corrected to read “RIN 0910-AH08”.
3. On page 37687, in the second column, the RIN number under the Instructions sub-heading is corrected to read “RIN 0910-AH08”.
Dated: November 10, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-27038 Filed 11-14-14; 8:45 am]
BILLING CODE 4164-01-P